Search
Search
We are committed to helping you accelerate the downstream purification of your vaccines. Explore our key resources for implementing resins in various vaccine modalities, such as protein subunits, virus-like particles, and viral vectors.
| Asset type | Title | Description | |
| Article | Addressing Challenges Across the Virus-Like Particle Workflow | Read to understand how an integrated system of tools for protein expression, affinity purification, and quality control testing can help support efficient and cost-effective Virus-Like Particle production on a commercial scale. | |
| Article | Affinity Tags Head Toward the Vaccination Clinic (C-tag) Purification | Learn how the Jenner Institute uses affinity tags to streamline malaria vaccine development. | |
| Article | How Affinity Tags are Speeding up Malaria Vaccine Development | Read to learn how the C-tag affinity tag system is applied as a standard purification process for candidate malaria vaccines to support efficient translation into clinical trials. | |
| Article | Purification and Quality Control Solutions to Accelerate Vaccine Development | Read to discover how novel chromatography solutions and analytical testing can help improve the downstream processes of different vaccine modalities. | |
| eBook | Intensify Vaccine Development with Innovative Purification | Gain more insights into various vaccine modalities and how they are efficiently purified through this collection of articles, webinars, and infographics. | |
| eBook | Managing Purity in Vaccines: How Advanced Purification Technologies Are Speeding the Hunt for New Protections Against Disease | Explore recent developments in the purification of various vaccine modalities such as VLPs, mRNA, and protein subunits through this collection of articles. |
To support the manufacturing of vaccines, we offer a broad variety of innovative purification solutions to improve the downstream processing of various vaccine modalities, including protein subunits, virus-like particles (VLPs), mRNA, and viral vectors.
For research use or further manufacturing. Not for diagnostic use or direct administration into humans or animals.